Timing of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

AIMS: Early studies from the 1990s have shown that statins improve survival and attenuate cardiac allograft vasculopathy (CAV). However, little contemporary data are available on the incremental benefit of statins with the current use of new‐generation immunosuppressive agents and the use of coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Asleh, Rabea, Briasoulis, Alexandros, Pereira, Naveen L., Boilson, Barry A., Edwards, Brooks S., Adigun, Rosalyn, Maltais, Simon, Daly, Richard C., Lerman, Amir, Kushwaha, Sudhir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300821/
https://www.ncbi.nlm.nih.gov/pubmed/30019530
http://dx.doi.org/10.1002/ehf2.12329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300821/
https://www.ncbi.nlm.nih.gov/pubmed/30019530
http://dx.doi.org/10.1002/ehf2.12329

Ejemplares similares